| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.29B | 39.75B | 38.79B | 36.52B | 29.18B | 22.67B |
| Gross Profit | 10.32B | 10.14B | 10.09B | 10.63B | 8.39B | 6.43B |
| EBITDA | 3.08B | 2.70B | 1.91B | 3.18B | 3.49B | 1.92B |
| Net Income | 881.41M | 629.46M | 176.93M | 799.55M | 1.78B | 974.49M |
Balance Sheet | ||||||
| Total Assets | 19.71B | 19.95B | 21.10B | 19.58B | 17.61B | 14.34B |
| Cash, Cash Equivalents and Short-Term Investments | 7.22B | 7.59B | 6.90B | 6.50B | 5.24B | 5.23B |
| Total Debt | 5.39B | 5.25B | 7.13B | 5.13B | 5.59B | 4.80B |
| Total Liabilities | 10.45B | 10.69B | 12.25B | 10.11B | 10.04B | 8.03B |
| Stockholders Equity | 8.97B | 8.95B | 8.42B | 8.81B | 6.99B | 5.70B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.69B | 946.83M | 1.82B | 2.70B | 1.10B |
| Operating Cash Flow | 0.00 | 3.12B | 1.76B | 2.85B | 3.08B | 1.42B |
| Investing Cash Flow | 0.00 | -147.41M | -2.37B | -1.90B | -2.54B | -1.81B |
| Financing Cash Flow | 0.00 | -2.41B | 934.08M | 141.47M | -546.57M | 1.73B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥20.42B | 17.55 | ― | 0.90% | 17.75% | 44.95% | |
73 Outperform | ¥19.04B | 7.63 | ― | 2.36% | -2.68% | -12.83% | |
73 Outperform | ¥8.73B | 11.18 | ― | 0.95% | 9.36% | -1.69% | |
69 Neutral | ¥19.48B | 43.69 | ― | 2.13% | -0.62% | -11.36% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ¥19.63B | 17.48 | ― | 1.72% | 26.24% | 29.73% | |
45 Neutral | ¥10.96B | -3.21 | ― | 5.03% | 3.97% | 63.06% |